1. Home
  2. BLUE vs MYND Comparison

BLUE vs MYND Comparison

Compare BLUE & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLUE
  • MYND
  • Stock Information
  • Founded
  • BLUE 1992
  • MYND 1998
  • Country
  • BLUE United States
  • MYND United States
  • Employees
  • BLUE N/A
  • MYND N/A
  • Industry
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • MYND Other Consumer Services
  • Sector
  • BLUE Health Care
  • MYND Real Estate
  • Exchange
  • BLUE Nasdaq
  • MYND Nasdaq
  • Market Cap
  • BLUE 36.9M
  • MYND 38.8M
  • IPO Year
  • BLUE 2013
  • MYND 2017
  • Fundamental
  • Price
  • BLUE $4.98
  • MYND $0.83
  • Analyst Decision
  • BLUE Hold
  • MYND
  • Analyst Count
  • BLUE 7
  • MYND 0
  • Target Price
  • BLUE $44.60
  • MYND N/A
  • AVG Volume (30 Days)
  • BLUE 750.4K
  • MYND 46.1K
  • Earning Date
  • BLUE 05-20-2025
  • MYND 05-20-2025
  • Dividend Yield
  • BLUE N/A
  • MYND N/A
  • EPS Growth
  • BLUE N/A
  • MYND N/A
  • EPS
  • BLUE N/A
  • MYND N/A
  • Revenue
  • BLUE $83,807,000.00
  • MYND $267,380,999.00
  • Revenue This Year
  • BLUE $218.58
  • MYND N/A
  • Revenue Next Year
  • BLUE N/A
  • MYND N/A
  • P/E Ratio
  • BLUE N/A
  • MYND N/A
  • Revenue Growth
  • BLUE 184.12
  • MYND N/A
  • 52 Week Low
  • BLUE $3.56
  • MYND $0.61
  • 52 Week High
  • BLUE $28.60
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • BLUE 63.73
  • MYND 52.30
  • Support Level
  • BLUE $3.20
  • MYND $0.74
  • Resistance Level
  • BLUE $4.45
  • MYND $0.92
  • Average True Range (ATR)
  • BLUE 0.20
  • MYND 0.09
  • MACD
  • BLUE 0.04
  • MYND 0.02
  • Stochastic Oscillator
  • BLUE 99.44
  • MYND 46.43

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

Share on Social Networks: